Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May 3;49(9):4245-56.
doi: 10.1021/ic100080k.

Is vanadate reduced by thiols under biological conditions? Changing the redox potential of V(V)/V(IV) by complexation in aqueous solution

Affiliations

Is vanadate reduced by thiols under biological conditions? Changing the redox potential of V(V)/V(IV) by complexation in aqueous solution

Debbie C Crans et al. Inorg Chem. .

Abstract

Although dogma states that vanadate is readily reduced by glutathione, cysteine, and other thiols, there are several examples documenting that vanadium(V)-sulfur complexes can form and be observed. This conundrum has impacted life scientists for more than two decades. Investigation of this problem requires an understanding of both the complexes that form from vanadium(IV) and (V) and a representative thiol in aqueous solution. The reactions of vanadate and hydrated vanadyl cation with 2-mercaptoethanol have been investigated using multinuclear NMR, electron paramagnetic resonance (EPR), and UV-vis spectroscopy. Vanadate forms a stable complex of 2:2 stoichiometry with 2-mercaptoethanol at neutral and alkaline pH. In contrast, vanadate can oxidize 2-mercaptoethanol; this process is favored at low pH and high solute concentrations. The complex that forms between aqueous vanadium(IV) and 2-mercaptoethanol has a 1:2 stoichiometry and can be observed at high pH and high 2-mercaptoethanol concentration. The solution structures have been deduced based on coordination induced chemical shifts and speciation diagrams prepared. This work demonstrates that both vanadium(IV) and (V)-thiol complexes form and that redox chemistry also takes place. Whether reduction of vanadate takes place is governed by a combination of parameters: pH, solute- and vanadate-concentrations and the presence of other complexing ligands. On the basis of these results it is now possible to understand the distribution of vanadium in oxidation states (IV) and (V) in the presence of glutathione, cysteine, and other thiols and begin to evaluate the forms of the vanadium compounds that exert a particular biological effect including the insulin-enhancing agents, antiamoebic agents, and interactions with vanadium binding proteins.

PubMed Disclaimer

Figures

Figure 1
Figure 1
51V (top) and 1H (bottom) NMR spectra of solutions containing vanadate (12.0 mM) and 2-mercaptoethanol (12.0 mM) at pH 8.20±0.05. The spectra were recorded at 300 ± 1 K.
Figure 2
Figure 2
The pH dependence of complex [1] and vanadate monomer [V1] is shown. Data points were obtained by quantitative 1H and 51V NMR spectroscopy on solutions containing vanadate (4.0 mM) and 2-mercaptoethanol (12.0 mM) in the absence of KCl.
Figure 3
Figure 3
Plots of complexes [1] (signal at −362 ppm) and [2] (signal at −385 ppm) as a function of [H2VO4]2[H2L]2 (here H2L = HOCH2CH2SH) and [1]2, respectively. Data points were obtained by quantitative 1H and 51V NMR spectroscopy.
Figure 4
Figure 4
Solution structure for the 2:2 vanadium complex with 2-mercaptoethanol, 1, and two likely structures for the 4:4 vanadium complex with 2-mercaptoethanol, 2. Only one of several possible stereoisomers is shown.
Figure 5
Figure 5
51V NMR spectra of solutions containing KVO3 (50 mM) and 2-mercaptoethanol (50 mM) at pH 8.25 ± 0.05. CH3CN is added up to 87 wt%, and spectra at 0, 68, 75, 81, 84 and 87 wt% are shown.
Figure 6
Figure 6
EPR spectra recorded in solutions containing VOSO4 (10 mM) and increasing concentrations of 2-mercaptoethanol (from 0 to 200 mM) in 0.60 M borate buffer (pH 9.6).
Figure 7
Figure 7
Normalized EPR spectra recorded in solutions with VOSO4 (10 mM) and 2-mercaptoethanol (200 mM) at pH 3.2 to 13.4.
Figure 8
Figure 8
The concentration of complex 3 and [VO(OH)3] ([VO(OH)3(H2O)2]) are shown as a function of pH. Data points were obtained by quantitative EPR spectroscopy in solutions with VOSO4 (10 mM) and 2-mercaptoethanol (200 mM). No complex signal is observed outside the pH region 8 – 14. The smooth line combining the experimental points for [3] and [VO(OH)3] is calculated using the stability constants and the reaction VO2+ + 2 HOCH2CH2S formula image [VO(OCH2CH2S)2]2− + 2 H+.
Figure 9
Figure 9
Plot of complex [3] in borate buffer at pH 9.6 as a function of [VO(H2O)52+][HL]2 (here HL = HOCH2CH2S). The linear relationship indicates a 1:2 complex stoichiometry for 3. Other possibilities result in non-linear plots (Figure S5).
Figure 10
Figure 10
Four possible solution structures for complex 3.
Figure 11
Figure 11
Absorption spectra of the vanadate- and vanadyl-2-mercaptoethanol complexes prepared under anaerobic conditions from vanadate (20 mM) and 2-mercaptoethanol (200 mM) at pH 8.9 at different times after the solution preparation: (a) 5 min; (b) 5 hours; and (c) at pH 3.0 (not time dependent).
Figure 12
Figure 12
The [1] and [2], [HOCH2CH2SH] and [(HOCH2CH2S)2] during the first 3 hours of reaction. The initial solution were added vanadate (200 mM), HOCH2CH2SH (200 mM), KCl (0.4 M) and borate buffer (0.4 M) at pH 8.95.

Similar articles

Cited by

References

    1. Crans DC, Zhang BY, Gaidamauskas E, Keramidas A, Roberts C. Abstracts of Papers. 223rd ACS National Meeting; Orlando, FL, United States. April 7–11, 2002; 2002. p. INOR-242.
    1. Hsu HF, Su CL, Gopal NO, Wu CC, Chu WC, Tsai YF, Chang YH, Liu YH, Kuo TS, Ke SC. Eur J Inorg Chem. 2006:1161–1167.
    1. Kawakami N, Ueki T, Amata Y, Kanamori K, Matsuo K, Gekko K, Michibata H. Biochim Biophys Acta -Prot Proteom. 2009;1794:674–679. - PubMed
    1. Ueki T, Shintaku K, Yonekawa Y, Takatsu N, Yamada H, Hamada T, Hirota H, Michibata H. Biochim Biophys Acta-Gen Subj. 2007;1770:951–957. - PubMed
    1. Singh S, Bharti N, Mohapatra PP. Chem Rev. 2009;109:1900–1947. - PubMed

Publication types